•   
  •   
  •   

US First 6.4 million doses of Pfizer’s coronavirus vaccine could go out in mid-December

02:15  25 november  2020
02:15  25 november  2020 Source:   washingtonpost.com

Vikings OL Dru Samia tests positive for COVID-19

  Vikings OL Dru Samia tests positive for COVID-19 Vikings offensive lineman Dru Samia has tested positive for COVID-19. Contact tracing is being performed, and Samia and anyone deemed a high-risk contact will not be permitted to travel with the team for tomorrow night’s game against the Bears. © Trevor Ruszkowski-USA TODAY Sports Samia, a 2019 fourth-rounder, started four games for Minnesota earlier this year before returning to a reserve role. But the Vikings just released Pat Elflein and now find themselves without their top backup at guard. Plus, there is a good chance that there will indeed be high-risk contacts given the nature of O-line/D-line play.

Germany-based BioNTech and Pfizer are jointly developing four potential vaccines . If one of the vaccines proves safe and effective in a large phase The vaccine would then be made available to Americans "at no cost," HHS said. It' s unclear who the first doses of the potential vaccine would go

Pfizer ' s coronavirus vaccine could be distributed to Americans before the end of the year if found to be safe and effective, CEO Albert Bourla said Sunday. The drugmaker should have key data from its late-stage trial for the Food and Drug Administration by the end of October, Bourla said during an

The federal government plans to send 6.4 million doses of pharmaceutical giant Pfizer’s coronavirus vaccine to communities across the United States within 24 hours of regulatory clearance, with the expectation shots will be administered quickly to front-line health-care workers, the top priority group, officials said Tuesday.

diagram: (FILES) U.S. government officials are on track to have 40 million doses of vaccines from Pfizer and a second company, biotech firm Moderna, by year's end, enough to vaccinate 20 million people. (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images) © Joel Saget/AFP/Getty Images (FILES) U.S. government officials are on track to have 40 million doses of vaccines from Pfizer and a second company, biotech firm Moderna, by year's end, enough to vaccinate 20 million people. (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images)

Gen. Gustave Perna, who oversees logistics for Operation Warp Speed, the Trump administration’s effort to speed up treatments and vaccines, told reporters that state officials were informed on Friday night of the allocation, which is based on each state’s overall population.

Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says.

  Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says. Moderna's candidate COVID-19 vaccine is even more effective that Pfizer's, trial results show. A "light at the end of the tunnel" for this pandemic.Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease.

Pfizer says it will begin testing the experimental vaccine in the United States as early as next week, and says a vaccine could be ready for emergency use in the Mainz-based BioNTech reported that the first cohort of participants had been given doses of the potential vaccine , BNT162, in a Phase

The Oxford coronavirus vaccine and Pfizer ' s jab are both in stage three human trials, with at least A Covid-19 vaccine may be rolled out by a Scottish NHS Trust in mid - December , according to GPs could receive the plans which set out how to deliver the vaccine 'potentially next week', according to

The amount would cover only a portion of the nation’s 20 million health care workers, let alone the U.S. population of 330 million. But Perna said “a steady drumbeat” of additional doses will be delivered as manufacturing capacity ramps up in each successive week.

With increased prospects that federal regulators will authorize the Pfizer vaccine on an emergency basis as early as mid-December, and the first shots administered before the end of the year, Operation Warp Speed has begun to release more details about the massive and complicated distribution effort to immunize tens of millions of Americans.

U.S. government officials are on track to have 40 million doses of vaccines from Pfizer and a second company, biotech firm Moderna, by the end of the year, enough to vaccinate 20 million people. (Each vaccine requires two doses). It is likely to be April before the general public begins to get vaccinated.

Pfizer to seek approval from FDA 'within days' after further analysis finds COVID-19 vaccine 95% effective

  Pfizer to seek approval from FDA 'within days' after further analysis finds COVID-19 vaccine 95% effective Pfizer and BioNTech are expected to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021. The news comes days after Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appeared to be 94.5% effective against COVID-19.

Though early results look promising, a lot can still go wrong. Here are five obstacles standing in the way. This is a BETA experience. You may opt- out by clicking here. Major drug companies like Pfizer , Moderna and others vying to create a Covid-19 cure are relying on a method For example, three doses of the polio vaccine is nearly 100 percent effective while the vaccine for measles is 93

mRNA vaccines : 30 million doses BioNTech/ Pfizer Inactivated whole virus vaccines : 60 million doses Valneva Janssen and Novavax vaccine trials go well, the first deliveries could take place in mid -2021.

The initial 6.4 million doses also includes vaccines that would go to five federal agencies — the Bureau of Prisons, the Defense and State departments, Indian Health Service, and the Veterans Health Administration — that receive allocations directly from the federal government.

States and territories now have the necessary information to “plan and figure out where they want the vaccine distributed” in the first shipment, Perna said. States are supposed to designate their top five sites capable of receiving and administering the Pfizer vaccine, which must be stored at ultracold temperatures of minus-70 Celsius (minus-94 Fahrenheit), and has exacting handling protocols. The ultracold temperature is significantly below the standard for most vaccines of 2-8 degrees Celsius (36-46°F).

Many states have designated large hospital systems to be the first places to receive vaccines because they have ultracold freezers and can efficiently vaccinate many people. The minimum order for the Pfizer vaccine is 975 doses; for Moderna, with a storage temperature that do not require such freezers, the minimum order is 100.

COVID vaccine candidate from Pfizer must be stored at minus 112, prompting a rush on dry ice

  COVID vaccine candidate from Pfizer must be stored at minus 112, prompting a rush on dry ice At minus 112, exposed skin freezes almost instantly. It’s also the temperature required to store what’s expected to be the first COVID-19 vaccine. Your browser does not support this video With last week's news that the vaccine candidate from Pfizer and its collaborator BioNTech was more than 90% effective and could be approved within a month, the reality of moving and storing the life-saving vials came into sharp focus.  © Gehm & Sons A scoop of dry ice pellets from Gehm & Sons, a fifth generation ice making company based in Akron, Ohio.

Another coronavirus vaccine trial participant, testing Pfizer ’ s candidate, similarly woke up with chills, shaking so High fever, body aches, bad headaches and exhaustion are just some of the symptoms five participants in two of the leading coronavirus vaccine trials say they felt after receiving the shots.

AstraZeneca will have 200m doses of its candidate vaccine developed by the University of Oxford by the Immunisations could begin in December if the regulators give the new vaccine the go -ahead Hancock referred to the dosage . Pollard has said that if people were given a half- dose first , followed

Once a vaccine is cleared by the FDA, an independent advisory panel to the Centers for Disease Control and Prevention — the Advisory Committee on Immunization Practices — will hold a public meeting within 48 hours to vote on final recommendations for the vaccine’s use and who should get the first shots. Health-care workers will be the first priority, the group has said. About three million residents of long-term care facilities are also likely to be included in that first phase. Next in line will be an estimated 87 million other essential workers, including first responders, teachers and grocery workers; more than 100 million adults with high-risk medical conditions; and about 53 million adults over the age of 65.

Within 24 hours of FDA action, doses will be “propositioned” at the sites designated by each state to give the shots to the first groups.

Pfizer has been conducting dry runs of each step, from vaccine delivery to opening Pfizer’s GPS-tracked special containers to vaccine storage, Perna said. The company began working last week with four states — Rhode Island, Texas, New Mexico, and Tennessee — to familiarize personnel with storage and handling requirements. These dry runs do not include actual vaccines, or the dry ice that will be used to keep the vials cold. Additional rehearsals in coming weeks will include dry ice, a federal health official said, speaking on the condition of anonymity because they were not authorized to speak publicly.

Broncos DC Ed Donatell back home recovering after COVID-related hospitalization

  Broncos DC Ed Donatell back home recovering after COVID-related hospitalization Broncos defensive coordinator Ed Donatell required hospitalization after contracting the coronavirus, according to the team. The second-year Denver DC was hospitalized last week but discharged Sunday. Donatell, 63, has been battling COVID-19 symptoms since Oct. 31 and has missed the past three games. Donatell, who is in his third stint with the franchise, is one of a few Broncos staffers to have contracted the virus. Running backs coach Curtis Modkins did so in October, and offensive line coach Mike Munchak was in the team’s COVID protocol.

Those “lessons learned” are being shared with other officials, Perna said. There was “initial hesitation” from some personnel at the sites, he said, but “we expect to see growing confidence in people that are using it.”

Americans will receive the vaccine free. The federal government is paying for much of the delivery and vaccine administration costs. But funding remains a big issue for state and local officials, who are asking Congress for at least $8 billion for vaccination efforts; to date, $200 million in federal funds has been sent to state, territorial and local jurisdictions to help them prepare. Federal officials are sending another $140 million in December.

Jeff Duchin, a top official at the Seattle and King County health department, said the more than $10 billion in taxpayer dollars spent on development of covid-19 vaccines by Operation Warp Speed was appropriate.

“But it’s been more like Operation Status Quo with respect to providing the federal funding needed for state and local health departments to actually get vaccine to the population, including the initial priority populations and ultimately, to as many people as possible,” he said in an email Tuesday.

State and local officials say much of the critical planning and implementation work needed for distribution is not adequately funded or staffed. That work includes planning with a broad range of health-care providers for the necessary training and upgrading information systems to vaccinate hard-to-reach and undeserved populations, Duchin said.

Health-care providers also need to track allocations, vaccinations administered and ensure people come back for second doses. Public health officials also need to do outreach with local communities that are hesitant about getting the vaccine, he said.

“Tens of millions of dollars are needed for this work in our county and state,” he said. “In addition, this work is tasked to local and state public health departments and workers, who have been grappling with this pandemic nonstop for months and are running on fumes.”

Vaccines Won't Stop the Pandemic Unless at Least 50 Million Skeptical Americans Change Their Minds .
More than four in 10 Americans say they won't get the COVID vaccine when it becomes available. Big problem: Even a highly effective vaccine won't do much to rein in the pandemic if enough people can't be persuaded to get the shot.It would be hard to exaggerate the degree to which experts have been surprised, and relieved, by these preliminary results. Early in the pandemic, conventional wisdom held that the best we could hope for was a slightly better hit rate than seasonal influenza vaccines, which in a good year protect 50 to 60 percent of those inoculated; the Food and Drug Administration set the target for COVID vaccines at a modest 50 percent.

usr: 3
This is interesting!